News

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...
In 1965, President Lyndon B. Johnson signed Medicare into law, dedicating it to former President Harry Truman, who "planted ...
Minnesota Gov. Tim Walz declared Wednesday "Medicaid and Medicare Day," and marked the day by discussing the anticipated ...
An estimated 4.4% of primary care physicians left Medicare in 2023 — a higher exit rate than specialists — according to a new ...
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...
Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...
Medicare is on shaky ground in the current policy environment, making it difficult to sustain its accomplishments, much less ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...